Category - Feature

Feature

Axolotl Biosciences developing bioink for 3D neural tissue bioprinting

Closely-held Axolotl Biosciences is developing a bioink specifically formulated for the bioprinting of neural tissue, for biotechnology and pharmaceutical companies to use for research and development purposes. “Last...

August 25, 2020

Feature

Chiasma readies U.S. launch of first oral somatostatin analog for acromegaly

On the heels of an FDA approval, Chiasma (NASDAQ:CHMA) is preparing for the U.S. launch of MYCAPSSA, the first orally administered somatostatin analog for the long-term maintenance treatment of acromegaly in patients...

August 18, 2020

Feature

Profound Medical’s TULSA-PRO prostate cancer treatment finds early adopter in Dr. Joseph Busch

As the founder of Atlanta’s renowned Busch Center, Dr. Joseph Busch Jr. brings a 40-year-plus track record in diagnostic radiology and hundreds of international research studies to preventative screening and accurate...

August 11, 2020

Feature

Prothena building diverse pipeline in multiple neurodegenerative and rare indications

Fueled by decades of research in protein dysregulation and fundamental neuroscience, Prothena (NASDAQ:PRTA) is advancing a pipeline of therapeutic candidates with the potential to change the course of diseases such as...

August 4, 2020

Feature

InspireMD advancing global distribution of CGuard EPS carotid stent for stroke prevention; gearing for U.S. pivotal trial

InspireMD (NYSE American:NSPR) is awaiting a decision from the FDA for an investigational device exemption as a steppingstone for a pivotal trial of its CE Mark-approved CGuard Carotid Stent System for the prevention of...

July 28, 2020

Feature

Soliton seeking FDA okay to treat cellulite with Rapid Acoustic Pulse

Soliton (NASDAQ:SOLY) has filed a 510(k) submission for FDA clearance of its Rapid Acoustic Pulse (RAP) technology for reduction in the appearance of cellulite, which affects between 80% and 90% of women. The FDA has...

July 21, 2020

Feature

NeuroOne developing electrode technology to treat neurological conditions

NeuroOne (OTCQB:NMTC) is developing high-definition, minimally invasive thin-film electrodes for the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson’s disease (PD) and chronic...

July 14, 2020

Feature

Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

Unlike the traditional approach to immunotherapy, which teaches the body to recognize tumor antigens as something foreign to be attacked, closely-held Loki Therapeutics’ AWAKE technology makes cancer appear as something...

July 7, 2020

Feature

Passage Bio developing transformative therapies for rare, life-threatening genetic disorders

Passage Bio (NASDAQ:PASG) is focused on developing transformative, differentiated therapies for rare, life-threatening monogenic CNS disorders, with the goal of mitigating development risk. “We believe that our rigorous...

June 30, 2020

Feature

CohBar developing therapeutics from mitochondrial DNA

CohBar (NASDAQ:CWBR) is transforming peptides encoded and expressed by mitochondria, some of which control a wide range of systems in the body, into novel therapeutics. “Harnessing the power of mitochondria biology to...

June 23, 2020

Category - Feature

Axolotl Biosciences developing bioink for 3D neural tissue bioprinting

Chiasma readies U.S. launch of first oral somatostatin analog for acromegaly

Profound Medical’s TULSA-PRO prostate cancer treatment finds early adopter in Dr. Joseph Busch

Prothena building diverse pipeline in multiple neurodegenerative and rare indications

InspireMD advancing global distribution of CGuard EPS carotid stent for stroke prevention; gearing for U.S. pivotal trial

Soliton seeking FDA okay to treat cellulite with Rapid Acoustic Pulse

NeuroOne developing electrode technology to treat neurological conditions

Loki Therapeutics harnessing antigens from traditional childhood vaccinations for immunotherapy

Passage Bio developing transformative therapies for rare, life-threatening genetic disorders

CohBar developing therapeutics from mitochondrial DNA

General

More